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The prognostic value of preoperative echocardiographic
data was assessed in 32 patients who underwent aortic
valve replacement for chronic aortic regurgitation. All
patients had preoperative studies and werefollow dup
prospectively for 1 to 6 years after surgery. Postoper-
atively, 25 patients (Group A) achieved a normal left
ventricular end-diastolic dimension and a significant
regression ofmyocardialhypertrophy;7 patients (Group
B) had persistent left ventricular enlargement. During
the follow-upperiod, the patients in Group A had fewer
symptomsand usedfewermedicationsthan thoseinGroup
B. Moreover, survival at 4 years appeared to be better
in Group A (96%) than in Group B (71%); two patients
in Group Bdied with congestive heart failure; there were
no such deaths in Group A.
Aortic valvereplacementprovidesconsiderablesymptom-
aticimprovementand decreased mortality when performed
in properlyselectedpatientswith chronic aortic regurgita-
tion(1-7). Unfortunately,suboptimalresults may occur in
those patients who havepreoperativeevidence of marked
leftventricularenlargement,elevatedfilling pressures and
reducedsystolicejectionfraction. Because these patients
also may presentincreasedsurgical risk, it would seem
importanto identify them beforehand. In this regard , a
substantialliteraturehasdevelopedand it appears that it is
possible to identify many patients who are at high risk of
persistentpostoperati ve symptoms and decreased postop-
erative survival(8- 21).
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Preoperatively, a leftventriculardimension at end-
diastole (DED)largerthan 3.8 cm/m! body surfacer a,
a dimension at end-systole (DES)greaterthan 2.6 cm/
m2 body surface area, an end-diastolic radius/wall thick-
ness ratio (R/Th) greater than 3.8 or aproductof R/Th
and leftventricularsystolicpressure (P·RlTh) exceeding
600 are predictive of a Group B result.Ifend-systolic
dimension isgreaterthan 2.6and P·RlTh isgreaterthan
600, all Group B patients can be identified; all but one
patient in Group A had an end-systolic dimension less
than 2.6 and P·RlTh less than 600.Itis concludedthat
patients with chronic aorticregurgitationwhoare at risk
of persistent postoperative leftventricularenlargement
(withassociatedcardiac symptomsand reduced survival)
can be identified by preoperative echocardiography.
There is little question that the symptomaticpatientwill
benefit from aortic valvereplacementunless there is very
severedepressionof cardiac function .Postoperativealle-
viation ofcongestivesymptoms is at least in partrelatedto
the decrease in leftventriculardiastolic pressure thatalmost
always occurs after thecorrectionof chronic aortic regur-
gitation. The problem,however,does not involve the symp-
tomatic patient with isolated aorticregurgitation;it is the
m nagement of the asymptomatic or minimallysymtomatic
patient that is difficult.It is well recognizedthat thechron-
ically volume-overloaded ventricle can develop irreversible
structural and functional changes, even if the patient does
not experience important symptoms. Such myocardial changes
could preclude a good surgical result and, for this reason ,
early aortic valve replacement may berecommendedfor
some patients in an attempt to prevent thedevelopmentof
leftventiculardysfunction.However ,prematurevalve re-
placement must be avoided because of the known compli -
cationsofprosthetic heart valves(7).Thedecisionto replace
the aortic valve inpatients with chronic aorticregurgitation
is, in fact, adecisiontoexchangeone disease (chronic aortic
regurgitation)foranother(prostheticvalve), If it were pos-
sible to identify reliable and specific clues that point to
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irreversible leftventriculardysfunction,these data could be
used to define limits beyond which one might not expect a
satisfactory surgical result. With thisknowledge,the patient
with chronic aortic regurgitation couldbefollowed up closely
and, if serial studies of leftventricularsize and function
indicateprogressiontoward these limits, it would seem rea-
sonable toproceedwith aortic valver placement,even in
the absence ofimportantsymptoms.It is conceivable that
information from a single test ormeasurementmight prove
sufficient to identify an optimal time for surgery, but it is
much more likely that serial studies or a combination of
tests, or both, would provide the reliable evidence needed
beforeproceedingwith surgery in a minimally symptomatic
or asymptomaticpatient.
The results of aprospectivestudy of patients undergoing
aortic valvereplacementfor chronic aortic regurgitation are
presented in this paper. Theseechocardiographicstudies
were initiallydesignedto assess the effects of aortic valve
replacement on leftventricularvolume, mass and function
(9); during the course of our studies it became apparent that
preoperativel ftventricularsize and function were impor-
tantdeterminantsof thepostoperativer sults and that pre-
operativeechocardiographicmeasurementshad consider-
ablepredictivevalue.Accordingly,in this article we con-
sider thepostoperativecourse of 32 patients who underwent
aortic valvereplacementand emphasizethe utility of the
echocardiogramin thepreoperativeassessment of patients
with chronic aorticregurgitation.
Methods
Studypatients.Thestudygroupconsistedof 32patientswho
underwentaortic valvereplacementforchronicaorticregurgitation
between1975 and 1980.Inclusionin this study waslimitedonly
by therequirementfordiagnosticqualityechocardiogramsand by
thepatients'willingnesstoparticipate.Theprotocolwasapproved
by theCommitteeon ResearchInvolvingHuman Beings of the
Tufts-NewEngland Medical CenterHospital.All patients had
isolatedchronicaorticregurgitationand thedecisionto perform
aortic valvereplacementwas based onclinicalandhemodynamic
criteria. In everypatienthe physicalexaminationindicated sig-
nificant aorticregurgitation,and theelectrocardiogramor chest
X-ray film, or both,reflectedleftventricularenlargement.Cardiac
catheterizationdata,includingangiographicevidenceofsubstantial
aorticregurgitation,confirmedthese clinicalimpressions.Three
patients(Cases 3, 27 and 30) hadassociatedcoronarybypass
surgery (single graft to the leftanteriordescendingcoronaryartery)
at the timeof aortic valvereplacement.None ofthe patients had
electrocardiographicor historicevidenceof previousmyocardial
infarction;nor did they haveevidenceforperioperativemyocardial
damage.One patient(Case 8) had apermanentpacemakerim-
planted.Clinical,echocardiographicandhemodynamicdata from
19 of thesepatientshavepreviouslybeenpublishedin an analysis
of theeffectsof aortic valvereplacementon leftventricularvol-
ume, mass andfunction(9).
Echocardiography.Echocardiogramswere obtainedwith a
Smith Klineultrosonoscopeand 2.25 MHztransducer.Left ven-
triculardimensionatend-diastole(DED) was measuredat the R
wave of thelectrocardiogram,and thedimensionatend-systole
(DES) was measuredas thesmallestverticaldimensionbetween
the left septal echo and theposteriorwall endocardiumat end-
systole.Posteriorwallthickness(Th) wasmeasuredatend-diastole
from the leading edge of theepicardialecho to theleadingedge
of theendocardialecho, with the gainadjustmentset tominimize
the width of these signals.Likewise,the septalthicknesswas
measured from the leading edgeof the right septalechoesto the
leading edge of the left septalechoes.Fractionalshortening(FS)
( xpressedas the percent change in leftv ntriculardimensionfrom
end-diastoletoend-systole)wascalculatedas:
FS = [(DED - DES)/DED] x 100.
Echocardiographic estimates ofleft ventricular volume are known
to be limited by several majorssumptions(22), and for this reason
we did not select a single method orreg essionequationto follow
the changes inchambervolume aftersurgery.Left ventricular
dimension atend-diastolewas used as an indexof end-diastolic
volume,and thepostoperativechangein this index wasfollowed
serially.
Echocardiographic estimation of left ventricular muscle mass
is likewisedependenton variousassumptionsregardingventricular
geometry.Thus, weelectedto use an indexof myocardialmass
that does not require theseassumptions.This index,termedthe
cross-sectionalrea (CSA) of theventricularwall in atransverse
plane, wascalculatedfrom theechographicdimensionand wall
thickness atend-diastole:
CSA = 7T[(DED/2) + Th]" - 7T(DED/2j",
where DED is theechographicdimensionatend-diastoleand Th
is theend-diastolicwall thickness.The indexof mass was cal-
culated serially in each patient toexaminethe timecourseof
regression of chronic volumeoverloadhypertrophy.The decision
to usecross-sectionalrea as an index of leftventricularmuscle
mass was made partly because we wished to avoidgeometric
assumptionsthat are likely to beimportantin thepostoperative
period. This method,evelopedby Sasayamaet al. (23), has been
used to follow changes in leftventricularmass in clinical and
experimentalstudies (9,II ).
Left ventricular relative wall thickness (radius tothicknessra-
tio) wasdeterminedfrom theechocardiographicstudy as:
R/Th = (DED/2)/Th,
where DED is thedimensionatend-diastoleand Th is the wall
thicknessatend-diastole.Within a broad range ofdimensionsand
mass, this index is linearly relatedto theend-diastolicvolume to
mass ratio. The product of systolicpressureand theend-diastolic
radius to thickness ratio was used as an indexofp ak systolic wall
stress(24,25).Arterial pressure wasmeasuredat the time of the
echocardiographicexaminationin eachpatient.
All 32 patients had evidence for left ventricular enlargement
(DED> 5.5 em or > 3.3 cm/m? of bodysurface,or both) (Table
I). In one patient(Case 17) theevidencecould beconsidered
borderlineby virtue of anend-diastolicdimensionof 5.5 ern;
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however, when thispatient'sdata were normalized for body size, defined two groups: Group A (25 patients) achieved a normal end-
she had definite left ventricular enlargement (3.7 cm/rrr'). In con-diastolic dimension in the postoperative period; Group B(7 pa-
trast, another patient (Case 9) had an end-diastolic dimension of tients) had persistent postoperative left ventricular enlargement in
7.7 cm (definite enlargement), but when data were normalized for the absence of aortic regurgitation. We have previously found this
body surface area, ventricular enlargement was borderline (3.2 method of grouping patients to be convenient, but the primary
crn/rrr'). The remaining 30 patients had left ventricular enlargementratio ale for this approach was based on the observations of Hirsh-
by both criteria. feld et al. (8). They found that the prognosis after aortic valve
Patientgroupsbasedon end-diastolicdimension.All 32 replacement was better in the patients with a decrease in the car-
patients had preoperative echocardiograms; postoperative studiesdiothoracic ratio than in those with a persistent increase in this
were obtained at 7 totodays and at3,6,9,12, 18 and 24 months ratio.
and annually thereafter. On the basis of postoperative data, weStatisticalanalysis.In the assessment of the preoperative util-
Table1. Preoperative Echocardiographic Data From 32 Patients With Chronic Aortic Regurgitation
Age (yr) BSA DED DES dD PW Th CSA P·R/Th BP HR NYHA
Case & Sex (m2) (em) (em) (%) (mm) (em') R/Th (mm Hg) (mm Hg) (beats/min) Class
GroupA
1 23M 1.9 6.5 4.0 38 1.0 24 3.3 528 160/45 70 Ii-
2 52M 1.8 7.8 5.6 28 1.1 31 3.5 665 190/60 55 2*
3 63M 2.1 7.2 4.2 41 1.1 29 3.3 570 190/40 50 2*
4 49M 2.0 7.0 4.1 41 1.0 25 3.5 630 180170 70 It
5 49M 1.9 6.5 4.3 34 0.9 21 3.6 594 165/60 65 2
6 IBM 1.8 6.9 4.2 39 1.3 33 2.7 378 \40/40 65 I
7 59F 1.5 6.2 4.7 24 0.8 \9 3.9 585 150170 60 3
8 58F 1.7 6.2 4.1 34 0.9 19 3.6 648 180/60 50 2
9 39M 2.4 7.7 5.6 27 1.0 26 3.9 546 140/40 75 2i-
10 41M 1.9 7.3 5.0 32 1.1 29 3.4 578 \70/50 70 2t
11 24M 2.\ 7.1 4.5 37 1.0 25 3.5 630 180/60 70 1
12 22M 2.3 6.9 4.8 30 1.1 29 3.1 465 150/50 85 2
13 34M 1.8 7.1 4.7 34 1.\ 28 3.2 512 160/60 80 2*
\4 36M 1.9 7.1 4.3 39 1.1 28 3.2 416 \30/60 60 I
\5 37M 1.9 7.5 5.3 29 1.1 30 3.3 594 180/40 95 1
\6 51M 1.7 7.6 6.1 20* 0.9 24 4.2 570 135/40 65 3
17 56F 1.5 5.5 3.7 33 0.7 14 3.9 429 110/50 60 3
18 58M 1.9 6.8 4.5 34 1.0 25 3.4 442 130/60 60 \
19 37M 2.1 8.2 6.0 35 1.0 29 4.1 574 \45/50 75 3
20 33M 1.9 7.0 4.5 36 1.0 25 3.5 473 135/55 65 I
21 34M 2.0 6.6 3.8 42 0.9 21 3.6 504 140/50 80 2
22 50M 1.8 6.0 3.5 42 1.1 25 2.7 365 135/55 90 2*
23 38M 1.7 6.5 4.0 38 0.9 21 3.6 468 130/60 85 2t
24 30M 1.9 6.9 4.7 32 \.4 32 2.5 388 \55/40 70 2
25 32M 1.9 7.0 4.7 33 1.1 28 3.2 448 140/50 75 2
Average 6.9 4.6 34 1.0 26 3.4 519
SD ±0.6 ±0.7 ±6 ±0.2 ±5 ±0.4 ±88
GroupB
26 23M 2.1 8.2 5.4 34 1.0 30 4.1 677 \65/40 60 1
27 50M 1.9 8.5 6.5 24 1.0 30 4.3 688 \60/60 80 2
28 52M 1.9 8.4 6.8 19 0.9 26 4.7 705 105/55 50 2*
29 67M 2.\ 8.0 5.5 3\ 1.0 28 4.0 760 190170 75 2
30 69M 1.9 7.6 5.1 33 1.0 27 3.8 608 160/45 55 3*
31 74F 1.3 6.6 5.0 24 0.9 2\ 3.7 629 170/60 65 3*
32 71M 1.9 8.0 6.0 25 1.0 28 4.0 600 150/40 85 3t
Average 7.9 5.8 27 1.0 27 4.1 667
SD ±0.6 ±0.7 ±6 ±O.I ±3 ±0.3 ±58
p <0.00\ <0.001 <0.005 NS NS <0.001 <0.001
'Oneepisodeofpulmonaryedema:rpasthistoryofendocarditis.
BP = bloodpressure:BSA = bodysurfacearea:CSA = cross-sectionalreaoftheventricularwall in atransverseplane:dO = tractionalchangein dimension:OED
= leftventriculardimensionatend-diastole:DES = leftventriculardimensionatend-systole:HR = heartrate.NS = notsignificant:NYHA = New York HeartAssociation
class:p = probability:P'R/Th = productofsystolicpressureand RITh: PW Th ~ posteriorwall thickness:R/Th = end-diastolicradius/thicknessratio:SO = standard
deviation.
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ity of thechocardiographicdata, we calculated sensitivity, spec-
ificityand predictive values of positive(+) and negative(-)
tests. The "diagnostic standard" is the presence or absence of a
normalend-diastolic dimension in thepostoperativestudies.Def-
initions are given below:
Sensitivity= true positives/true positives+ falsenegatives.
Specificity= true negatives/false positives+ truenegatives.
Predictive value(+) = true positives/true positives+ false
positives.
Predictive value (-) = truenegatives/falsen gatives+ true
negatives.
Normal range for the echographic variables wasdefinedas the
mean± 2 standard deviations (9). Serialpostoperativedata were
compared with control values and with each other using analysis
of variance and a Duncans test to locate the variance. When only
a single comparison was made, as in thepreoperativeGroup A
versus Group B, an unpairedt test was used. Changes were con-
sideredsignificantif the probability (p) value was less than 0.05.
Results
Echocardiographicdata.Preoperativechocardio-
graphicdata from32patientsarepresentedin TableI. The
averagevaluesfor severalof the echocardiographicvari-
ablesdiffersignificantlybetweenthe twogroups.Heartsize
(dimension atend-diastole[OED] and at end-systole[DES]),
end-diastolicrelativewall thickness(radiustothicknessra-
tio[R/Th])andR/Thnormalizedforsystolicpressure(P'RI
Th) werelargerinGroupB than inGroupA; fibershortening
was lowerin GroupB than inGroup A. As will beseen,
however,therewasconsiderableoverlapbetweenindividual
datapointsdespitethe significantdifferencebetweenav-
eragevaluesof many ofthepreoperativevariables.
Serial postoperative changes indimensionatend-diastole
andmusclecross-sectionalrea for the twogroupsare shown
in Figure 1. In Group A, dimensionat end-diastolede-
creasedfrom 3.7 ± 0.4 to 3.0 ± 0.5 cm/rrr'(p < 0.01)
at the timeof the earlypostoperativestudy.Therewas a
smalladditionaldecreasein dimensionatend-diastoleat 3
monthswhich did notachievestatisticalsignificanceand
there was nochangethereafter.Therewas nosignificant
differencein musclecross-sectionalareabetweenthe pre-
operative value(13.6 ± 2.3 cmvrrr')and the early post-
operative value(13.5 ± 2.7 cmvrrr').At 3 months,the
averagecross-sectionalarea wasreducedto 12.3 ± 2.3
cm2/m2 (p < 0.01);therewas afurtherdeclineat6 months
(10.5± 1.5cmvrrr',p < 0.01),but there was nosignificant
changethereafter.In Group B, there was nosignificant
postoperatived creaseindimensionatend-diastoleor cross-
sectionalarea.
Postoperativesurvival.In terms of the echocardio-
graphicdata,thesetwogroupsofpatientshad aconsiderably
different response to surgery. The data from these two groups
I
L,-:--.---r----.----"7I ,~
I
I
6
(months)
Figure 1. Left ventricularend-diastolicdimension (OED) and muscle
cross-sectional area (CSA) before and after aortic valve replacement. Twenty-
five patients (Group A, closedcircles)achieved a normal end-diastolic
dimension after surgery. whereas seven patients (Group B.opensquares)
had persistent leftventncularenlargement.The gradual reductionIn muscle
cross-sectionalrea seen in Group A reflects apostoperativer gression of
hypertrophy. BSA= body surface area: POST OP= time after operation:
PRE OP = before operation.
areshownin termsofsurvivalin Figure2.Twoofthe seven
patientsin GroupB died withcongestiveheart failure within
I yearofsurgery.One (Case26)died 9 monthsaftersurgery
and theother(Case30),who hadassociatedcoronaryartery
disease,died 6weeksaftersurgery.This latterpatientdid
not haveevidenceof perioperativemyocardialinfarction.
In contrast,there were nodeathsfrom congestiveheart
failurein GroupA; one patient(Case 9) died 9 monthsafter
surgerywithprostheticvalveendocarditisand asecondpa-
tient (Case 24) died 4 yearsfterepeatedattemptstorepair
recurrentparavalvularaorticregurgitation.Comparisonof
thesurvivaldata from the twogroups(Fig. 2) islimitedby
the smallnumberofpatients,but thisanalysisdoeshighlight
theexcellentprognosisin GroupA patients.
Postoperativefunctionalclassdata(Fig. 3). Mostof
ourpatientswere in New YorkHeartAssociationfunctional
class II or IIIbeforesurgery.Nine patientsdeniedsignificant
cardiorespiratorys mptoms;however,most of these did
admit anawarenessof precordialactivity,palpitationor
prominentcarotidpulsations.Of the 17Group A patients
infunctionalclass11 or III, functionalimprovementoccurred
in all but 4; 3 of these 4 hadparavalvularregurgitation.Of
the fivesurvivorsinGroupB, only twoshowedsymptomatic
improvement.In additionto thesechangesin functional
class,at latefollow-upthepatientsin GroupA weretaking
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Table2. Medications at Late Follow-up
Numbers Indicate (from left to right).
No of ptsAlive at beginningof time interwl
No.who Diedduringthe interval
Nowhohod not yet reached thenexti terval *Includes one patient taking an anuhypertensiveagent
()~'-:2;5-~I-:;;0~2:;:4~-~0-:-;3;-:;2~1-~0-::5:-;;16~-0~-::;4:-1""'l1~:JoI_-5-6-l_0J_-6-6-{]_O_0
~ 75- \. _ _
:s;; 7-2-1 5-0-1 4-0-0 3-0-2 3-0-1 1-0-0 0-0-0~
II)
~ 50-
r:::::
'q
;:l25-~
G
No cardiac drugs
Antihypertensivedrug
Digitalis
Digitalisand diuretic drug
Digitalis,diureucdrug
and unloadingagent
Group A
(n=25)
7 (28%)
1(4%)
9* (36%)
8* (32%)
o
Group B
(n=7)
o
o
1(14%)
3 (43%)
3 (43%)
I , , I , I ,
FUNCTIONAL CLASSIFICATION
Figure4. Preoperativeechocardiographicdata from all 32 patients. Group
A patients areindicatedby theclosedcirclesand Group B by theopen
squares.There isconsiderableoverlapbetween thesemeasurementsIn the
two groups.In general,however,a Group B result is likely if the left
ventriculardimensionatend-diastole(DED) exceeds3.8 cm/nr'.the di-
mension atend-systole(DES) exceeds2.6cm/nr',theend-diastolicradiusl
thicknessratio (R/Th)exceeds3.8 or the product of systolic pressure and
R/Th (P-R/Th)exceeds600 mm Hg. %6.D = percent change inchamber
dimension.
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Echocardiographiccriteriapredictiveof postopera-
tive course.In an attempt to identify preoperative echo-
cardiographic variables that might predict a suboptimal (Group
B) postoperativecourse,we examined the preoperative data
from all 32 patients. Because it is important to correctly
identifyall Group B patients, we selectedechocardiographic
criteria with 100% sensitivity; we then calculated the spec-
ificity andpredictivevalue of these criteria (Fig. 4). There
was considerableoverlap between individual echocardio-
graphic variables despite the significant differences between
group averages. Forexample,the best individual variable
(which identified all seven patients in Group B) was a
P·R/Th greater than 600 mm Hg, but four of the patients
in Group A were included and therefore classified incor-
rectly (85% specificity). We then analyzed theechocardio-
graphic variables in variouscombinationsand two of these
SURVIVORS
GROUP B (n=71
1Death
PREOPSURVIVORS
GROUP A (n=251
PREOP
Figure2. Cumulativesurvivalfollowingaortic valvereplacement.Sur-
vival in the Group A patients(opensquares)exceeds90% at 4 years;
there were no deaths due tocongestiveheart failure in this group. Within
) year ofsurgery,two Group B patients(closedcircles)died with conges-
tive heart failure. pts.= patients.
01234567
YEARS AFTER AORTIC It4LVE REPLACEMENT
Figure3. New York HeartAssociationfunctionalclassificationi the two
groups before and after aortic valvereplacement.Of the foursymptomatic
patients in Group A whoseconditiondid not improve(*). three had para-
valvularaorticregurgitation.Only two of the fivesurvivorsIn Group B
showedsymptomaticimprovement.
fewer cardiac medications than those in Group B (Table 2).
Approximatelyone-thirdof the patients in Group A were
taking no cardiac drugs, another third were taking digitalis
and another third were using digitalis and a diuretic agent.
In contrast,all seven Group B patients were taking cardiac
drugs; six of the seven were taking digitalis and a diuretic
agent with or without an unloading agent (hydralazine).
Thus, in addition to the significant decrease in left ventric-
ular dimension atend-diastoleandcross-sectionalarea in
Group A, these patients appear to have improved survival,
experiencebetter functional classification and utilize fewer
cardiac medications than the Group B patients. Because the
patients in Group A were using fewer medications than those
in Group B, the better functional classification of Group A
cannot bexplainedon the basis of medical treatment alone.
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are shown in Figure 5. All seven Group B patients had a
preoperative dimensionat end-diastole greater than3.8and
adimensionat end-systole greater than2.6; however, values
in four patients in Group A were also in this range (85%
specificity). If the preoperative value for P·R/Th is greater
than 600and dimension at end-systole is greater than 2.6,
all seven Group B patients areidentified(100% sensitivity)
andonly one Group A patient is included (96% specificity).
The predictive value of a positive test (P·R/Th > 600and
dimensionat end-systole > 2.6) is 87%, whilethe predictive
value of a negative test (P·R/Th< 600 and dimension at
end-systole< 2.6) is 100%. With these preoperative cri-
teria, 97% of our patients were correctly classified.
Discussion
Symptomsas predictorsof postoperativecourse,Pa-
tients with chronicaorticegurgitationgenerally experience
a longasymptomaticperiod that may last for decades. Dur-
ing this protracted clinical course, important depression of
left ventricularfunction maydevelop-evenin theabsence
of serious symptoms. Such changes are notunif rmly seen,
but when present, they are exceedingly important because
they may precludean optimal result aftersurgical correction
of the regurgitation. On the other hand, the presence of
cardiac symptoms does not necessarily indicate irreversible
changes in ventricular function. In fact, most symptomatic
patients show a marked improvement after aortic valve re-
placement.Thus, although irreversible changes in left ven-
tricularfunction may be present in theasymptomaticpatient,
such changes are not uniformlyfound, nor are they nec-
essarily present in the patient with symptoms. In the present
study, thepreoperativesymptoms were similar in bothgroups
and had little utility in predicting the postoperative results.
Cardiac symptoms are sometimes quite difficult to eval-
uate in patients with chronic aortic regurgitation. Many pa-
tients admit an increased awareness of precordial activity
and some complain ofpalpitation; although these patients
are generally consideredto be in New York Heart Asso-
ciationfunctionalclass I, thesignificance of these symptoms
is unknown. In patients with aortic regurgitation, typical
angina is rare in the absence of coronary artery disease(2) .
This symptom is probably also unreliable as an indicator of
the functional state of the left ventricle. Moreover, it is
sometimes impossible to determine whether fatigue is a
consequence of reduced cardiac reserve. Symptoms of pul-
monary venous congestion, however, herald a phase that is
associated with an ominous prognosis unless aortic valve
eplacement isundertaken. Before the development of this
symptom, the physical examination and other clinical data
provideonly limitedinformationregarding thefunctional
state of the leftventricle. Thus, there is great need for more
definitivemethods to evaluate patients with chronic aortic
regurgitation. Because echocardiography provides a safe,
inexpensive and widely available technique to evaluate and
monitor changes in left ventricularvolume, mass and func-
tion, it has been used in many studies of chronic aortic
regurgitation.
Echocardiographicdimensionsas predictorsof op-
erativeresults.Several reports havedocumentedsubstan-
ti l reductions in left ventricular volume and mass after
surgicalcorrectionof chronic aorticregurgitation (9,11,15).
These studies indicate that most of the decrease in volume
occurs early after valve replacement, but thereduction in
ss is much more gradual, taking at least 6 months. Un-
fortunately, however, some patients do not achieve a sig-
nificantreductioninventricular volumeor myocardial mass.
Our data indicate that postoperative echocardiography al-
lows theidentification of two distinct groups of patients
ba d on the presence (Group A) or absence (Group B) of
a normal end-diastolic dimension. The Group A patients
have aremarkably good survival rate (over 90% at 4 to 5
years), experience fewer symptoms and use fewer cardiac
medications than those in Group B. A major purpose of this
report, however, was to examine thepredictive utility of
4
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Figure S. Preoperative cchocardrographic data from 32
patients. In the left panel, end-diastolic dimension (OED>
is plotted against end-systolic dimension(DES) for two
groups. This analysis indicates that those panents with an
end-diastolic dimension greater than 3.8 cm/nr'and an
end-systolicdimension greater than 2 6 cm/m?are at high
risk of persistent postoperative left ventricular enlarge-
ment. Although this analysis yields four false positive
results. it has the advantageof requiring only Simple mea-
surements that are made routinely m all clinical ecbocar-
diography laboratories. In the right panel, the product of
systolic pressure and the end-diastolic radius/thickness ra-
110 (P,y,,·R/Th)I ~ used as an index of aflerload and is
plotted against end-systolic dimension(DES). With use
of the limits of 600 mm Hgand 2.6cm/m",respectively.
all Group B patients are Identified With only one false
positive result; thai IS. 96% of the panents are correctly
classified.
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thepreoperativeechocardiogram,and in this regard several
variables are ofconsiderablevalue in predicting the post-
operativeresults.
In general,marked leftventricularenlargementand es-
pecially a very large end-systolic dimension identify a high
risk patient.Henry et al. (15) found a high incidence of
congestiveheart failure or death, or both, in those patients
with apreoperativeend-systolic dimension greater than 55
mm. Similarly, Kumpuris et al. (21) found that values greater
than 50 mm were predictive of irreversible cardiac dilation.
Our data confirm andcomplementhese two studies. All
seven patients in Group B had values for end-systolic di-
mension of 50 mm or more; only four patients in Group A
had values greater than 55 mm. We corrected our mea-
surementsfor body surface area because of the wide range
of body size in our patients (range 1.3 to 2.4rrr')and found
that values for end-systolic dimension that exceed 2.6cml
rrr'identify the high risk patient. However, analyses of our
data indicate that single preoperativeechocardiographic
variables are of limited prognostive value, but that certain
combinationsof these variables have remarkable predictive
value.Specifically,measurements of end-diastolic or end-
systolic dimension in an individual patient are relatively
weak indicators of the subsequent postoperativecourse, while
thecombinationof end-systolicand end-diastolic dimen-
sion, orend-systolicdimensionand end-diastolic radiusl
thickness ratio corrected for systolic pressure(P'R/Th)are
very useful prognostic clues.
Predictiverole of systolic wall stress.Although all pa-
tients in Group A had evidence of left ventricular enlarge-
ment, over half of this group had normal or near normal
values forP'RlTh (and presumably normal peak systolic
wall stress). The rationale for using the product of systolic
pressure andend-diastolicR/Th as an index of wall stress
has previously been reported in detail(24,25).This main-
tenance of normal systolic wall stress in the presence of left
ventricularenlargementis due to the appropriate increase
in wall thickness that develops in patients with compensated
chronic volumeoverloadand eccentric hypertrophy (11);
fibershorteningin such hearts is generally normal. Dimen-
sion atend-systoleremained normal or near normal in the
patients with normal values forP'R/Th(Fig. 5). Even when
end-diastolicdimensionapproached3.8cm/m/andP'R/Th
approached600, end-systolic dimension remained near nor-
mal in most patients. These patients all did well after sur-
gical correction of the aorticegurgitation.Even an in-
creasedend-systolicdimension does not necessarily carry
an ominous prognosis when systolic wall stress(P'R/Th)
remains below 600 mm Hg. However, when theP'R/Th
exceeds 600 (reflecting greatly increased systolic wall stress)
and the dimension at end-systole exceeds 2.6 cm/rn? (re-
flectingdecreasedshortening),the probable outcome is per-
sistentpostoperativel ftventricularenlargement( he Group
B response).
Potentiallimitationsofmeasurements.It has recently
beensuggestedthat vasodilators or leftv ntricularunloading
agents might be beneficial for patients with chronic aortic
regurgitation,andit is possible that these agents could in-
fluence leftventricularsize and function and perhaps even
the natural history of chronic aortic regurgitation (26). If
this were to occur, the limits of 2.6 and 600 might be
different in treated patients. The presence of coronary artery
dis ase or aging could also affect these variables. Another
potential limitation of this analysis relates to the accuracy
andreproducibilityof theechocardiographicmeasurements.
We havepreviouslyemphasizedthe importance of small
measurementerrors in the calculation of these echocardio-
gr phic indexes of leftventricularfunction (24). The mea-
surements of wall thickness and even systolic pressure are
subject to modest errors that can substantially change the
values forP·R/Th.For this reason the simplicity of the
analysisillustratedin the left panel of Figure 5 is appealing;
although themeasurementsof end-diastolic and end-systolic
dime sionsare made routinely in allechocardiographylab-
oratories,even thesestraightforwardmeasurements may be
misleading if they are used to estimate the systolic ejection
fraction. Despite these potential limitations, the published
data indicater markableagreement among several groups.
Our findings and those of others confirm the utility of echo-
cardiographyin the identification of high risk patients with
aorticregurgitation(9,12,15,16,21,27).
Clinicalimplications.After having defined the limits
of leftventricularsize and function beyond which an ideal
response to aortic valvereplacementcannot bexpected,it
would seemreasonableto use these limits in the decision-
making process involving patients with chronic aortic re-
gurgitation. Although it is known that left ventricular dys-
function may develop in the absence of important symp-
toms, precise guidelines regarding the timing of surgery in
such patients are not yet available. However, if an asymp-
tomatic patient meets the Group B criteria at the time of the
initialpresentationand if other clinical information, in-
cludingradionuclideand cardiaccatheterizationdata, is con-
sonant with theechocardiographicdata (indicating left ven-
triculardysfunction),we believe that aortic valve replace-
ment should be performed. Because asymptomatic or min-
imallysymptomaticpatients who present with marked left
ventricularenlargementand depressed contractility com-
monly have anunsatisfactoryresponse to aortic valve re-
placement,it would appear that surgery should be consid-
ered before the patient enters the high risk subgroup (Group
B).
This leads to the problem of a patient who presents with
borderline data (Fig. 5). Because it appears important to
operate before the patient enters Group B, one might con-
sider aortic valver placementin some patients who meet
the criteria for Group A, but who are near the upper limits
of normal for this group.Unfortunately,the rate of pro-
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gression of change in these patients is not well known, and
for this reason it could beacceptableto examine the patient
at least twice a year andcarefullysearch for signs indicating
a progressive change in leftventricularsize or function.
Exercise stress testing might beesp ciallyvaluable in eval-
uating such patients(27,28).The dilemma is not yet re-
solved, but if the risk of surgery is low,"early"aortic
valvereplacementis probably indicated in some Group A
patients,especiallyif other data indicate abnormal left ven-
tricular function.Obviously,the echocardiographicdata
should beexaminedin concertwith all clinical data before
the decision toperformaortic valve surgery is made.
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